Immunologic and virologic effects of glucocorticoids on human immunodeficiency virus infection in children: a preliminary study

Pediatr Infect Dis J. 1994 Mar;13(3):212-6. doi: 10.1097/00006454-199403000-00009.

Abstract

The immune dysfunction in human immunodeficiency virus (HIV) infection is complex and cannot be explained solely on the basis of numerical depletion of T lymphocytes. Inappropriate, uncontrolled activation of the immune system may be involved. In a test of this hypothesis, five HIV-infected children were prospectively treated with prednisone and selected immunologic and virologic indices were analyzed. Subjects had marked T lymphopenia (CD4+ T lymphocytes < 500 cells/ml) and antigenemia (serum p24 antigen > 30 pg/ml) and were free of opportunistic infections. There was a significant drop in serum p24 antigen concentrations from baseline (60.2 +/- 10.1% SEM; P < 0.005) 4 weeks after initiation of prednisone, which returned to baseline concentrations as the prednisone was tapered. Concomitant with this decrease, there was decreased expression of cell surface activation markers (HLA-DR, CD25 (interleukin 2 receptor) and CD26 (Ta-1)) in peripheral T lymphocytes. There was no significant change in either T lymphocyte subset numbers or mitogen and antigen-specific lymphoproliferation. A regulatory dysfunction of the immune system, allowing inappropriate activation of T lymphocytes, may be involved in the pathogenesis of HIV disease, and further studies involving selective immunosuppression in HIV disease are warranted.

MeSH terms

  • CD4-CD8 Ratio
  • CD4-Positive T-Lymphocytes / immunology*
  • Child
  • Child, Preschool
  • HIV Core Protein p24 / blood*
  • HIV Infections / immunology*
  • HIV Infections / microbiology
  • Humans
  • Leukocyte Count
  • Lymphocyte Activation
  • Phenotype
  • Prednisone / pharmacology*
  • Prospective Studies
  • T-Lymphocyte Subsets / immunology*

Substances

  • HIV Core Protein p24
  • Prednisone